- Home
- BHAT vs NERV Comparison
BHAT vs NERV Comparison
Compare BHAT & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- NERV
- Stock Information
- Founded
- BHAT 2010
- NERV 2007
- Country
- BHAT China
- NERV United States
- Employees
- BHAT N/A
- NERV N/A
- Industry
- BHAT Recreational Games/Products/Toys
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- NERV Health Care
- Exchange
- BHAT Nasdaq
- NERV Nasdaq
- Market Cap
- BHAT 12.3M
- NERV 12.0M
- IPO Year
- BHAT 2019
- NERV 2014
- Fundamental
- Price
- BHAT $1.77
- NERV $2.18
- Analyst Decision
- BHAT
- NERV Hold
- Analyst Count
- BHAT 0
- NERV 1
- Target Price
- BHAT N/A
- NERV $5.00
- AVG Volume (30 Days)
- BHAT 1.1M
- NERV 21.3K
- Earning Date
- BHAT 04-30-2025
- NERV 11-04-2025
- Dividend Yield
- BHAT N/A
- NERV N/A
- EPS Growth
- BHAT N/A
- NERV N/A
- EPS
- BHAT N/A
- NERV 1.48
- Revenue
- BHAT $18,724,190.00
- NERV N/A
- Revenue This Year
- BHAT N/A
- NERV N/A
- Revenue Next Year
- BHAT N/A
- NERV N/A
- P/E Ratio
- BHAT N/A
- NERV $1.52
- Revenue Growth
- BHAT N/A
- NERV N/A
- 52 Week Low
- BHAT $1.51
- NERV $1.15
- 52 Week High
- BHAT $45.00
- NERV $3.00
- Technical
- Relative Strength Index (RSI)
- BHAT 54.51
- NERV 51.60
- Support Level
- BHAT $1.62
- NERV N/A
- Resistance Level
- BHAT $2.02
- NERV $2.18
- Average True Range (ATR)
- BHAT 0.17
- NERV 0.10
- MACD
- BHAT 0.01
- NERV -0.11
- Stochastic Oscillator
- BHAT 44.44
- NERV 87.90
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.